Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 3, Issue 3, 2022

Research on the Application Value of Combinative Monitoring of Blood Β-HCG and Progesterone in Treatment of Ectopic Pregnancy

Download as PDF

DOI: 10.23977/medsc.2022.030318 | Downloads: 7 | Views: 542

Author(s)

Jialan Chen 1, Xin Shen 1, Qinfeng Liu 2, Zhuo Deng 3

Affiliation(s)

1 Gynecology Department, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
2 Medical Equipment Management Department, Shaanxi Provincial People's Hospital, Xi'an, 710068, China
3 Xin Shen

Corresponding Author

Qinfeng Liu

ABSTRACT

Objective To investigate the value of combined detection of serum HCG and progesterone in the treatment of ectopic pregnancy (EP). Methods The initial value and average daily decrease within 7 days of blood β-HCG and progesterone monitored during hospitalization in 47 EP patients were retrospectively analyzed, and the correlation between them and the expectant treatment Results was analyzed. Results The success rate of expectant treatment decreased with the increase of initial blood β-HCG and progesterone. The group with initial blood β-HCG ≤ 1000 mIU / ml had the best expectant effect, and the difference was significant (P = 0.001 < 0.05). The group with initial progesterone ≤ 10 ng / ml had the best expectant effect, and the difference was also significant (P = 0.000 < 0.05). After 7 days expectant treatment, the greater the average daily decrease of blood β-HCG and progesterone, the higher the success rate. Among them, the average daily decease of ≥ 10 % had the highest success rate. There was significant difference in the success rate of the three groups (P < 0.05). Conclusion The combinative monitoring of blood β-HCG and progesterone can provide reliable data for the effective prediction of the EP expectant treatment outcome, which has a very high clinical diagnostic value.

KEYWORDS

β-HCG, Progesterone, Ectopic pregnancy, Combinative monitoring, Expectant treatment

CITE THIS PAPER

Jialan Chen, Xin Shen, Qinfeng Liu, Zhuo Deng, Research on the Application Value of Combinative Monitoring of Blood Β-HCG and Progesterone in Treatment of Ectopic Pregnancy. MEDS Clinical Medicine (2022) Vol. 3: 118-124. DOI: http://dx.doi.org/10.23977/medsc.2022.030318.

REFERENCES

[1] Farquhar C M. Ectopic pregnancy [J]. Lancet, 2005, 366(9485): 583-591.
[2] Creanga A A, Syverson C, Seed K, et al. Pregnancy-Related Mortality in the United States, 2011-2013[J]. Obstet Gynecol, 2017, 130(2): 366-373.
[3] Kirk E, Papageorghiou AT, Condous G, et al. The diagnostic effectiveness of an initial transvaginal scan in detecting ectopic pregnancy [J]. Hum Reprod, 2007, 22(11): 2824-2828.
[4] Kong F, Y Li, X Liu. Effect and clinical value of coagulation test on adverse reactions of blood transfusion in patients with major bleeding in ectopic pregnancy[J]. Exp Ther Med, 2018, 16(6): 4712-4716.
[5] Wang YH, Zhu L. Advances in treatment of ectopic pregnancy [J]. National Medical Journal of China, 2021, 101(7): 524-526.
[6] Committee-On-Practice-Bulletins Gynecology. ACOG Practice Bulletin No. 191: Tubal Ectopic Pregnancy [J]. Obstetrics and gynecology, 2018, 131(2): e65-e77.
[7] Zhang CC. Clinical analysis of 60 cases of ectopic pregnancy expectancy therapy [J]. Chinese Community Doctors, 2012, 14(17): 17.
[8] Wu YL. Clinical efficacy and feasibility of expectant therapy for ectopic pregnancy [J]. Chinese Journal of Clinical Rational Drug Use, 2013, 6(01): 123.
[9] Qi XY, Su SL, Dong BH. Factor analysis of successful treatment for ectopic pregnancy [J]. National Medical Journal of China, 2013, (15): 1165-1167.
[10] Yan WJ. Discussion on the current situation and trend of ectopic pregnancy treatment [J]. Health Way, 2018, 17(07): 18.
[11] Elson J, Tailor A, Banerjee S, et al. Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis [J]. Ultrasound Obstet Gynecol, 2004, 23(6): 552-556.
[12] Sukhwani M, Antolin E, Herrero B, et al. Management and perinatal outcome of selective intrauterine growth restriction in monochorionic pregnancies [J]. J Matern Fetal Neonatal Med, 2021, 34(23): 3838-3843.
[13] Jurkovic D, Memtsa M, Sawyer E, et al. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial [J]. Ultrasound Obstet Gynecol, 2017, 49(2): 171-176.
[14] Shalev E, Peleg D, Tsabari A, et al. Spontaneous resolution of ectopic tubal pregnancy: natural history [J]. Fertil Steril, 1995, 63(1): 15-19.
[15] National-Guideline-Alliance UK. Diagnostic accuracy of ultrasound features for tubal ectopic pregnancy: Ectopic pregnancy and miscarriage: diagnosis and initial management: Evidence review A [M]. London: National Institute for Health and Care Excellence (NICE), 2019: e19-e20.
[16] Yang HL. Analysis of the clinical value of blood β-HCG and progesterone detection in the diagnosis of early ectopic pregnancy[J]. Contemporary Medical Symposium, 2016, 14(01): 40-41.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4691
Visits: 204481

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.